Titlebook: Chronic Viral Hepatitis; Diagnosis and Therap Raymond S. Koff,George Y. Wu Book 20021st edition Springer Science+Business Media New York 20

PHONE

offense

Hepatitis C and HIV Co-Infection,eaths among people with acquired immune deficiency syndrome (AIDS) declined for the first time in 1996, after the institution of this therapeutic approach. As the life expectancy of HIV-infected patients increases, greater attention will need to be focused on the recognition and management of potent

micturition

locus-ceruleus

橡子

Treatment of Chronic Hepatitis C Infection,ubclinical, yet there is a high rate of chronicity after infection. As many as 55–85% of individuals who contract HCV infection will develop chronic infection and hepatitis. Of these, at least 20% will progress to cirrhosis after a 10–30 yr period, and are at risk to develop hepatocelluplar carcinom

調整

Treatment of Chronic Viral Hepatitis in Patients with Autoimmune Diseases,s associated with hepatitis C . and, to a lesser extent, hepatitis B .; many of these conditions are mediated through autoimmune mechanisms. Shortly after the release of interferon α-2b (IFN-α2b) for the treatment of these viral infections came reports of autoimmune disorders that were either caused

ORBIT

Developing Therapeutic Plans for Patients with Chronic Hepatitis B or C,patient with chronic viral hepatitis involves taking care of the entire patient, anticipating the needs and potential problems for each patient, and educating the patient regarding their disease and its management. Developing the therapeutic plan and initiating treatment for the patient with chronic

踉蹌

Supporting the Patient with Chronic Hepatitis During Treatment,ific problem with therapy, but in addition the therapy itself is complex, and is associated with a multitude of side effects. This chapter examines strategies for the management of side effects in patients treated with both interferon (IFN) and IFN—ribavirin combination therapy. In the clinical tria

天真

Complementary and Alternative Treatment of Liver Disease,the past decade, the proportion of Americans who report using alternative or complementary therapies has grown from 34 to 42%. During that interval, the projected number of total visits to alternative practitioners increased by 47%, from 427 million visits/yr in 1991 to 629 million visits/yr in 1997

獨行者